Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancer

MLA

Asaka, Shiho, et al. “Association of Glutaminase Expression with Immune-Suppressive Tumor Microenvironment, Clinicopathologic Features, and Clinical Outcomes in Endometrial Cancer.” International Journal of Gynecological Cancer, vol. 34, no. 11, Nov. 2024, pp. 1737–44. EBSCOhost, https://doi.org/10.1136/ijgc-2024-005920.

APA

Asaka, S., Verma, N., Yen, T.-T., Hicks, J. L., Nonogaki, H., Shen, Y.-A., Hong, J., Asaka, R., DeMarzo, A. M., Wang, T.-L., Shih, I.-M., Gaillard, S., & Foote, J. (2024). Association of glutaminase expression with immune-suppressive tumor microenvironment, clinicopathologic features, and clinical outcomes in endometrial cancer. International Journal of Gynecological Cancer, 34(11), 1737–1744. https://doi.org/10.1136/ijgc-2024-005920

Chicago

Asaka, Shiho, Neha Verma, Ting-Tai Yen, Jessica L Hicks, Hiro Nonogaki, Yao-An Shen, Jiaxin Hong, et al. 2024. “Association of Glutaminase Expression with Immune-Suppressive Tumor Microenvironment, Clinicopathologic Features, and Clinical Outcomes in Endometrial Cancer.” International Journal of Gynecological Cancer 34 (11): 1737–44. doi:10.1136/ijgc-2024-005920.